News

Neonatal diabetes research paper receives “Distinguished Clinical Research Award”

November 8th, 2016

A publication resulting from collaboration between the Monogenic Diabetes team in Exeter and colleagues in Abu Dhabi has received the “Distinguished Clinical Research Award” from the American Association of Clinical Endocrinologists, Gulf Chapter. You can access the paper here.

slide1


Blood Sciences lab received new state-of-the-art robot

August 22nd, 2016

The Blood Sciences laboratory has taken delivery of a state-of-the-art robot to improve the translational research undertaken in the department. The £130,000 robot was bought by the University of Exeter in recognition of the award winning collaborative research undertaken in partnership between the Royal Devon and Exeter Hospital and the University of Exeter Medical School. Professor Noel Morgan, the Director of the Institute of Biomedical and Clinical research at the University of Exeter was there for the unveiling of the new robot.

Read more:https: //hub.exe.nhs.uk/a-z/newsroom

blood-sciences-new-robot

(Picture left to right- Professor Noel Morgan (Director of the  Institute of Biomedical and Clinical Research, UoEMS), Adrian Cudmore (Laboratory manager), Rachel Nice (Research BMS), Dr Tim McDonald (Clinical Scientist), Dr Mandy Perry (Clinical Scientist)- New robot in the back ground!)

 


South West celebrates 100,000 Genomes Project

July 4th, 2016

Families affected by rare conditions or cancer across the South West are having their genomes sequenced as part of a national bid to shed new light on the genetic causes of disease.

Since launching in December 2014, the South West NHS Genomics Medicine Centre (SWGMC) has enrolled 372 patients with a rare disease, or cancer, for genome sequencing to understand more about their condition. Nearly 4000 samples will be provided by hospitals across the South West.

On 28 June, patients and their families  joined  with healthcare professionals from across the region to celebrate the project. The South West NHS Genomics Medicine Centre is a partnership between 7 NHS hospitals in Devon, Cornwall and Somerset, supported by the South West Academic Health Science Network.  The 100,000 Genomes Project was announced by the Prime Minister in 2012 to transform diagnosis and treatment for patients with cancer and rare diseases in the fast-emerging field of genomic medicine.

Opening the day,  Professor Sue Hill, Chief Scientific Officer at NHS England,  described  the aims of the national project and how it will shape future healthcare. Professor Sian Ellard, Director of the South West NHS Genomic Medicine Centre and Professor of Genomic Medicine at the University of Exeter Medical School, reported local progress before two families talked about their experience of the project.

Professor Ellard explained why this project is so important:

“Genomic medicine will improve healthcare in many ways, through better diagnosis and treatment of rare diseases and increased knowledge of cancer biology to devise better therapies. We’re really proud of the contribution we have made to the national goal of sequencing 100,000 genomes and would like to share our progress with those involved – healthcare staff, patients and their families.”

The role of the SWGMC is to enroll patients to the project and to communicate the genome sequencing results back to patients. One of those patients is Aidan Scholey. Seven-year-old Aidan is the first member of the Scholey family to show signs of a rare genetic condition, and his mother Maria hopes the 100,000 Genomes Project will help provide some answers.

Aidan’s condition is so rare that it has not yet been diagnosed with a named condition. His parents were not worried when he was born small, but over time Aidan’s lack of growth gave clues that his development was showing signs of a disease. Still small for his age, Aidan also has a retinal dystrophy that impairs his vision.

Maria Scholey, who lives in Exeter, said: “Aidan is a happy, placid and much-loved little boy. We’re hoping that a genetic diagnosis would give us more information about the longer term implications of his condition and how it might develop. Genetic therapies are also a rapidly-evolving area of medicine, so it is possible that getting involved could mean that Aidan could receive help in future.”

The family has provided blood samples to the South West NHS Genomics Centre. It is hoped that the genome sequencing will provide a diagnosis for Aidan and others like him – but the family is aware that it may not find the answer.

Mrs Scholey said: “It would be great to get a diagnosis for Aidan, but even if we don’t, we see our involvement as part of a bigger picture. It’s possible that we may even find out something we don’t want to know about the way Aidan’s condition will develop – but this is far bigger than just one child. It’s about contributing to information that can be shared worldwide and could help others. It’s the future of medicine.”

For more information, please contact: Marie Taylor on 01392 – 408208 or mobile 07730427592

scholeys

Mr and Mrs Scholey with Aiden and Erin

NHS_01

From the left: Rosie Benneyworth, Managing Director of SW Academic Health Science Network; Professor Sian Ellard, Director of the South West NHS Genomic Medicine Centre; Dr Charles Shaw-Smith, Consultant Clinical Geneticist and SW GMC Rare Disease Lead


Trainee Scientists inspiring the next generation at the Big Bang Fair SW 2016

June 30th, 2016

Trainee scientists enrolled on the NHS Scientist Training Programme (STP) spent the day at Exeter University participating in the regional Big Bang Fair, with activities to engage and inspire young people 11-17 years old to take STEM subjects and look to careers within the NHS. STP trainees from hospitals in Exeter, Bristol and Bath representing several specialisms (Genetics, Clinical Bioinformatics, Vascular Sciences and Reconstructive Sciences) enjoyed the day talking to the children and demonstrating the sort of jobs healthcare scientists do, getting the children involved and encouraging them to ask questions. The activities including modelling prosthetics, assembling a genome, examining blood vessels with an ultrasound scanner, extracting DNA from peas and karyotyping socks!

We had a very busy day with lots of students, teachers and home-educating parents from across the South-West region visiting the stand and we think we’ve inspired a few healthcare professionals of tomorrow.

For more information about the Big Bang Fair SW go to http://nearme.thebigbangfair.co.uk/south_west/.

The STP team

From L-R: Hazel Pearce (Genetics STP), Christopher Curd (Vascular Science STP), Charlotte Tudgay (Genetics STP), Ryan Ward (Vascular Science STP), Verity Fryer (Bioinformatics – Genomics STP), John Hignett (Genetics STP), Laura Hamilton (Medical Student), Stuart Cannon (Bioinformatics – Genomics STP), Amy Davey (Reconstructive Science STP)


New Cobas e-601 Random Access Analyser

June 27th, 2016

As of Tuesday 21st June 2016, we have moved some Virology  Serology Testing (HIV, Hepatitis B surface antigen, Hepatitis B core antibody, Hepatitis C antibody, Syphilis antibody, HTLV  and Hepatitis B surface antibody)  onto the Cobas e-601 random access analyser.

cobas e601

 

The only difference you should notice is the wording on some of these reports – please see below for examples:

Negative samples will be reported as Non-reactive

POSITIVE samples will be reported as REACTIVE

Click here for report examples

 


Transfusion News May 2016

June 20th, 2016

Transfusion News for website May 2016


MWE Universal Transport Medium

May 25th, 2016

In compliance with GSI standards, MWE have adopted a new expiry date format for its product labels.

The main change is that the expiry date is now shown as a six digit code, i.e. YYMMDD, where YY is the last 2 digits of the year, MM is the month (from 01 January to 12 December), and DD is the date show as 2 digits (from 01 to 31).

To demonstrate, an expiry code of 180201 means the expiry date is; 1st February 2018.

This information has also been added to the RD&E intranet IaN.


The Guardian writes about personalised treatment for Monogenic Diabetes

May 11th, 2016

Yesterday, the Guardian published an account of some of the developments in personalised genomic medicine showcasing some quotes from our own Professor Sian Ellard.

Read the full article here.


Monogenic Diabetes Team at the Royal Devon & Exeter wins BMJ ‘Diabetes Team of the Year’

May 9th, 2016

The Monogenic Diabetes Team at the Royal Devon and Exeter NHS Foundation Trust took home the BMJ ‘Diabetes Team of the Year’  award from the ceremony hosted on the 5th May. Working collaboratively with the University of Exeter Medical School has resulted in what the judges’ remarked as a “rapid translation of world-leading research into clinical practice” for better monogenic diabetes care. The transformational work on monogenic diabetes has helped people across the country and around the world by ensuring monogenic diabetes can be correctly identified, diagnosed and managed. For more information about the winners see the BMJ Awards Brochure or visit http://thebmjawards.bmj.com/home.

For more information about monogenic diabetes see http://www.diabetesgenes.org/.


Next round of MOOC in Genomic Medicine starts 25th April

April 20th, 2016

The next installment of the Genomic Medicine: Transforming Patient care in Diabetes MOOC, produced by the University of Exeter, begins on the 25th April so don’t forget to sign up! Follow this link to the course homepage for more details:

https://www.futurelearn.com/courses/diabetes-genomic-medicine/1